[Federal Register Volume 63, Number 26 (Monday, February 9, 1998)]
[Notices]
[Page 6575]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-3097]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meetings
Pursuant to Section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
National Institute on Drug Abuse (NIDA) Special Emphasis Panel
meetings.
Purpose/Agenda: To review and evaluate grant applications.
Name of Committee: NIDA Special Emphasis Panel (Organization and
Management of Drug Abuse Treatment Services).
Date: March 4, 1998.
Time: 8:30 a.m.
Place: Key Bridge Marriott Hotel, 1401 Lee Highway, Arlington,
VA 22209.
Contact Person: Raquel Crider, Ph.D., Scientific Review
Administrator, Office of Extramural Program Review, National
Institute on Drug Abuse, 5600 Fishers Lane, Room 10-22, Telephone
(301) 443-9042.
Name of Committee: NIDA Special Emphasis Panel (Strategic
Program for Innovative Research on Cocaine (and other Psychomotor
Stimulants) Addiction Pharmacotherapy).
Date: March 18-19, 1998.
Time: 8:30 a.m.
Place: Holiday Inn Bethesda, 8120 Wisconsin Avenue, Bethesda, MD
20852.
Contact Person: Khursheed Asghar, Ph.D., Scientific Review
Administrator, Office of Extramural Program Review, National
Institute on Drug Abuse, 5600 Fishers Lane, Room 10-22, Telephone
(301) 443-2620.
The meetings will be closed in accordance with provisions set
forth in sections 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. The
applications and/or proposals and the discussions could reveal
confidential trade secrets or commercial property such as patentable
material and personal information concerning individuals associated
with the applications and/or proposals, disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
(Catalog of Federal Domestic Assistance Program Numbers: 93.277,
Drug Abuse Research Scientist Development and Research Scientist
Awards; 93.278, Drug Abuse National Research Service Awards for
Research Training; 93.279, Drug Abuse Research Programs)
Dated: January 30, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-3097 Filed 2-6-98; 8:45 am]
BILLING CODE 4140-01-M
